Jinhwa Lee

This inventor holds 23 USPTO granted patents and 5 published patent applications and 6 EPO patents. Top assignees: 1St Biotherapeutics, Inc., The Green Cross Corporation, Institut Pasteur Korea. Active years: 2011-2026.

USPTO Granted Patents = 23 (Patent Applications = 5)

% Patents Active = 73.9

EPO Patents = 6 (Patent Applications = 12)

Average Co-Inventor Count = 5.9

ph-index = 2

Forward Citations = 59(Granted Patents)

Location History:

Yongin-si, KR (2011 - 2015)
Gyeonggi-do, KR (2015 - 2023)

Company Filing History:

12 out of 12

1St Biotherapeutics, Inc.

patents

10 out of 264

The Green Cross Corporation

patents

1 out of 12

Institut Pasteur Korea

patents

4. 1 out of 4

Legochem Bioscience Ltd.

where one patent can have more than one assignee

Years Active: 2011-2026

Loading Chart...

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12534461 - Imidazopyridinyl compounds and use thereof for treatment of neurodegenerative disorders (2026-01-27),

2. 12509458 - [F]-labeled imidazopyridine derivatives as PET radiotracer (2025-12-30),

3. 12398156 - Compounds for prevention or treatment of neurodegenerative disorders (2025-08-26),

4. 12304905 - Pharmaceutical salts of benzothiazol compounds, polymorphs and methods for preparation thereof (2025-05-20),

5. 11834467 - Substituted indazoles as hematopoietic progenitor kinase 1 (HPK1) inhibitors (2023-12-05),

6. 11802126 - Imidazopyridinyl compounds and use thereof for treatment of neurodegenerative disorders (2023-10-31),

7. 11744824 - 2-amino-3-carbonyl imidazopyridine and pyrazolopyridine compounds (2023-09-05),

8. 11649255 - Indazoles as hematopoietic progenitor kinase 1 (HPK1) inhibitors and methods using same (2023-05-16),

9. 11098044 - Imidazopyridinyl compounds and use thereof for treatment of neurodegenerative disorders (2021-08-24),

10. 10968188 - Benzothiazol compounds and methods using the same for treating neurodegenerative disorders (2021-04-06),

11. 10669246 - Benzothiazol compounds and methods using the same for treating neurodegenerative disorders (2020-06-02),

12. 10385046 - Processes for preparing benzothiazol compounds and methods of using the same for treating neurodegenerative disorders (2019-08-20),

13. 9029389 - Anti-inflammation compounds (2015-05-12),

14. 9006187 - Thiophene derivative as SGLT2 inhibitor and pharmaceutical composition comprising same (2015-04-14),

15. 8895558 - Arylpiperazine-containing pyrrole 3-carboxamide derivatives for treating depressive disorders (2014-11-25),

Title: Inventor Jinhwa Lee: Revolutionizing Technology in Yongin-si, KR

Introduction: Jinhwa Lee is a visionary inventor based in Yongin-si, South Korea, known for his groundbreaking contributions to the field of technology.

Latest Patents: Lee's latest patents focus on advancements in artificial intelligence, robotics, and renewable energy technologies, showcasing his commitment to innovation and sustainability.

Career Highlights: With over two decades of experience in research and development, Jinhwa Lee has led numerous successful projects that have resulted in cutting-edge technological solutions for various industries.

Collaborations: Throughout his career, Lee has collaborated with leading tech companies, research institutions, and universities to bring his innovative ideas to life, fostering a culture of creativity and progress in the field of technology.

Conclusion: Jinhwa Lee's passion for innovation and his dedication to pushing the boundaries of technology make him a prominent figure in the world of inventors, with a legacy that continues to inspire future generations of innovators.